Renaissance Technologies’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-341,200
| Closed | -$6.64M | – | 3706 |
|
|
2018
Q1 | $6.64M | Sell |
341,200
-938,100
| -73% | -$18.4M | 0.01% | 1639 |
|
|
2017
Q4 | $21.3M | Buy |
1,279,300
+649,200
| +103% | +$11.9M | 0.02% | 905 |
|
|
2017
Q3 | $12.8M | Buy |
630,100
+267,900
| +74% | +$5.12M | 0.02% | 1177 |
|
|
2017
Q2 | $5.83M | Sell |
362,200
-181,900
| -33% | -$2.69M | 0.01% | 1613 |
|
|
2017
Q1 | $6.88M | Sell |
544,100
-548,902
| -50% | -$6.63M | 0.01% | 1494 |
|
|
2016
Q4 | $14.5M | Buy |
1,093,002
+915,302
| +515% | +$15.6M | 0.02% | 991 |
|
|
2016
Q3 | $4.21M | Buy |
+177,700
| New | +$4.78M | 0.01% | 1713 |
|
|
2016
Q2 | – | Sell |
-117,700
| Closed | -$3.77M | – | 3640 |
|
|
2016
Q1 | $3.77M | Buy |
117,700
+33,900
| +40% | +$1.19M | 0.01% | 1824 |
|
|
2015
Q4 | $3.58M | Buy |
+83,800
| New | +$3.35M | 0.01% | 1715 |
|
|
2015
Q3 | – | Sell |
-14,100
| Closed | -$647K | – | 3496 |
|
|
2015
Q2 | $647K | Sell |
14,100
-57,800
| -80% | -$2.74M | ﹤0.01% | 2640 |
|
|
2015
Q1 | $3.37M | Buy |
71,900
+10,500
| +17% | +$418K | 0.01% | 1620 |
|
|
2014
Q4 | $1.95M | Buy |
61,400
+22,000
| +56% | +$644K | ﹤0.01% | 1807 |
|
|
2014
Q3 | $934K | Buy |
+39,400
| New | +$1.01M | ﹤0.01% | 2059 |
|
|
2014
Q2 | – | Sell |
-1,046,000
| Closed | -$27.6M | – | 3099 |
|
|
2014
Q1 | $27.6M | Sell |
1,046,000
-362,300
| -26% | -$9.05M | 0.07% | 356 |
|
|
2013
Q4 | $35.4M | Buy |
1,408,300
+343,100
| +32% | +$7.65M | 0.08% | 274 |
|
|
2013
Q3 | $21.8M | Buy |
1,065,200
+118,900
| +13% | +$2.46M | 0.05% | 445 |
|
|
2013
Q2 | $18.9M | Buy |
+946,300
| New | +$16.8M | 0.05% | 469 |
|
Renaissance Technologies's IPXL Position: Q2 2018 in Review
Renaissance Technologies sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 341,200 shares — an estimated $6.64M sold.
Renaissance Technologies first reported a position in IPXL in Q2 2013 and held it in 17 quarters. The position peaked at $35.4M in Q4 2013. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.
- Renaissance Technologies reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
- Renaissance Technologies sold 341,200 Impax Laboratories, Inc. shares in Q2 2018, an estimated $6.64M.
- Renaissance Technologies first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 17 quarters.
- Renaissance Technologies's Impax Laboratories, Inc. position peaked at $35.4M in Q4 2013.
- 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.
Based on Renaissance Technologies's 13F filing for Q2 2018, filed 13 Aug 2018.